Loading…
Lobbying Income
$7.9M
Filings
220
Unique Clients
15
Active Period
2001–2010
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: FEDERATION OF AMERICAN HOSPITALS
Provide background information regarding the political and policy status of health care reform, including the development and structuring of health reform initiatives and how they could impact the hospital sector (including but not limited to HR 3200).
Client expense: — · Firm income: —
Matched citations: HR 3200
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: FEDERATION OF AMERICAN HOSPITALS
Provide background information regarding the political and policy status of health care reform, including the development and structuring of health reform initiatives and how they could impact the hospital sector (including but not limited to HR 3200).
Client expense: — · Firm income: —
Matched citations: HR 3200
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1427
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1427
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1548
Pathway for Biosimilars Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1548
Pathway for Biosimilars Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1548
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3200
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3200
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION
Advocate for initiatives designed to improve safety, enhance quality and constrain costs through generic utilization and pharmacy management techniques; advocate for the creation of a workable, science-based regulatory pathway for access to affordable generic biologic medications (including but not limited to H.R. 1427, S. 726, H.R. 1548, H.R. 3200)
Client expense: — · Firm income: $20,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1427
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1548
Pathway for Biosimilars Act
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1548
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: HR 3200
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: HR 3200
Preserving Equitable Access to Community-based Home Health (PEACH) Act of 2009
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: HR 3495
Preserving Equitable Access to Community-based Home Health (PEACH) Act of 2009
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: HR 3495
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET
Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.
Client expense: — · Firm income: $10,000
Matched citations: S. 726
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: SERVICE EMPLOYEES INTERNATIONAL UNION
Advocate for policies designed to improve the long-term care delivery structure by providing home and community-based state options, addressing health care workforce shortages and ensuring quality in care delivery as well as health reform initiatives to ensure adequacy of subsidies/tax credits to achieve affordable coverage for the under 65 population (including but not limited to HR 3200, HR 3495).
Client expense: — · Firm income: $15,000
Matched citations: HR 3200
Source: Senate LDA